Boston Scientific Lotus valve

EuroIntervention

Volumn 8, Issue , 2012, Pages Q70-Q74

  Meredith, Ian T ^a   Hood, Kristin L ^b   Haratani, Nicole ^b   Allocco, Dominic J ^b   Dawkins, Keith D ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ASTHMA; BODY MASS; CLINICAL OUTCOME; COMORBIDITY; EQUIPMENT DESIGN; EUROSCORE; FEMALE; FEMUR FRACTURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PRESSURE; HIP FRACTURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NEW YORK HEART ASSOCIATION CLASS; PATIENT SELECTION; REVIEW; SCLERODERMA; SCREENING; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; EQUIPMENT; EVIDENCE BASED MEDICINE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; METHODOLOGY; PATHOPHYSIOLOGY; PROSTHESIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885431914     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8SQA12     Document Type: Review

References (10)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-8.
2. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-704.
3. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-95.
4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
5. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
6. Piazza N, Lange R, Martucci G, Serruys PW. Patient selection for transcatheter aortic valve implantation: patient risk profile and anatomical selection criteria. Arch Cardiovasc Dis. 2012;105:165-73.
7. Van Mieghem NM, Head SJ, van der Boon RM, Piazza N, de Jaegere PP, Carrel T, Kappetein AP, Lange R, Walther T, Windecker S, van Es GA, Serruys PW. The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention. 2012;8:258-66.
8. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57: 253-69.
9. Meredith I. Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System: Discharge/7-Day Outcomes in the REPRISE I Study. Paris Course on Revascularization, Paris, France, 2012.
10. Meredith I, Hood K, Allocco D, Dawkins K. The Lotus Valve System. Cardiac Interventions Today. 2012;6; in press.